Hepatitis C tripeptide inhibitors

Details for Australian Patent Application No. 2002248147 (hide)

Owner Bristol-Myers Squibb Company

Inventors Good, Andrew; Campbell, Jeffrey, Allen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002248147

PCT Pub. Number WO2002/060926

Priority 60/249,968 20.11.00 US

Filing date 20 November 2001

Wipo publication date 12 August 2002

Acceptance publication date 6 April 2006

International Classifications

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248147

6 April 2006 Application Accepted

  Published as AU-B-2002248147

3 August 2006 Standard Patent Sealed

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248148-MODIFICATION OF SOY FLOUR PROTEINS FOR PRODUCING COAGULANTS IN PAPERMAKING AND WASTE WATER TREATMENT APPLICATIONS

2002248146-A DISPOSABLE PACKAGE FOR A VOLATILE LIQUID